{"id":"https://openalex.org/W1985238075","doi":"https://doi.org/10.1046/j.1365-2141.2002.03708.x","title":"Mutation in the ATP\u2010binding site of BCR\u2010ABL in a patient with chronic myeloid leukaemia with increasing resistance to STI571","display_name":"Mutation in the ATP\u2010binding site of BCR\u2010ABL in a patient with chronic myeloid leukaemia with increasing resistance to STI571","alternate_titles":[],"publication_year":2002,"publication_date":"2002-10-01","ids":{"openalex":"https://openalex.org/W1985238075","doi":"https://doi.org/10.1046/j.1365-2141.2002.03708.x","mag":"1985238075","pmid":"https://pubmed.ncbi.nlm.nih.gov/12358910"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2141.2002.03708.x","doi":"https://doi.org/10.1046/j.1365-2141.2002.03708.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1365-2141.2002.03708.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2141.2002.03708.x","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1985238075"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2141.2002.03708.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089814079","display_name":"Christophe Barthe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christophe Barthe","raw_affiliation_strings":["Laboratoire de Greffe de Moelle et Laboratoire d'h\u00e9matologie, Universit\u00e9 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France","Laboratoire de Greffe de Moelle et Laboratoire d'h\u00e9matologie, Universit\u00e9 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Greffe de Moelle et Laboratoire d'h\u00e9matologie, Universit\u00e9 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France","institution_ids":["https://openalex.org/I3018323443"]},{"raw_affiliation_string":"Laboratoire de Greffe de Moelle et Laboratoire d'h\u00e9matologie, Universit\u00e9 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and","institution_ids":["https://openalex.org/I3018323443"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023399139","display_name":"Gharbi Mj","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marie\u2010jos\u00e9e Gharbi","raw_affiliation_strings":["Laboratoire de Greffe de Moelle et Laboratoire d'he\u0301matologie, Universite\u0301 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and","Laboratoire de Greffe de Moelle et Laboratoire d'h\u00e9matologie, Universit\u00e9 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Greffe de Moelle et Laboratoire d'he\u0301matologie, Universite\u0301 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and","institution_ids":["https://openalex.org/I3018323443"]},{"raw_affiliation_string":"Laboratoire de Greffe de Moelle et Laboratoire d'h\u00e9matologie, Universit\u00e9 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and","institution_ids":["https://openalex.org/I3018323443"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030620023","display_name":"Val\u00e9rie Lagarde","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Val\u00e9rie Lagarde","raw_affiliation_strings":["Laboratoire de Greffe de Moelle et Laboratoire d'he\u0301matologie, Universite\u0301 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and","Laboratoire de Greffe de Moelle et Laboratoire d'h\u00e9matologie, Universit\u00e9 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Greffe de Moelle et Laboratoire d'he\u0301matologie, Universite\u0301 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and","institution_ids":["https://openalex.org/I3018323443"]},{"raw_affiliation_string":"Laboratoire de Greffe de Moelle et Laboratoire d'h\u00e9matologie, Universit\u00e9 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and","institution_ids":["https://openalex.org/I3018323443"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056355845","display_name":"Claudine Chollet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Claudine Chollet","raw_affiliation_strings":["Laboratoire de Greffe de Moelle et Laboratoire d'he\u0301matologie, Universite\u0301 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and","Laboratoire de Greffe de Moelle et Laboratoire d'h\u00e9matologie, Universit\u00e9 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Greffe de Moelle et Laboratoire d'he\u0301matologie, Universite\u0301 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and","institution_ids":["https://openalex.org/I3018323443"]},{"raw_affiliation_string":"Laboratoire de Greffe de Moelle et Laboratoire d'h\u00e9matologie, Universit\u00e9 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and","institution_ids":["https://openalex.org/I3018323443"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044166434","display_name":"Pascale Cony\u2010Makhoul","orcid":"https://orcid.org/0000-0002-1633-6479","observed_orcids":["https://orcid.org/0000-0002-1633-6479"]},"institutions":[{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pascale Cony\u2010Makhoul","raw_affiliation_strings":["Laboratoire de Greffe de Moelle et Laboratoire d'he\u0301matologie, Universite\u0301 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and","Laboratoire de Greffe de Moelle et Laboratoire d'h\u00e9matologie, Universit\u00e9 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Greffe de Moelle et Laboratoire d'he\u0301matologie, Universite\u0301 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and","institution_ids":["https://openalex.org/I3018323443"]},{"raw_affiliation_string":"Laboratoire de Greffe de Moelle et Laboratoire d'h\u00e9matologie, Universit\u00e9 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and","institution_ids":["https://openalex.org/I3018323443"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109927617","display_name":"Josy J. Reiffers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Josy Reiffers","raw_affiliation_strings":["Laboratoire de Greffe de Moelle et Laboratoire d'he\u0301matologie, Universite\u0301 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and","Laboratoire de Greffe de Moelle et Laboratoire d'h\u00e9matologie, Universit\u00e9 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Greffe de Moelle et Laboratoire d'he\u0301matologie, Universite\u0301 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and","institution_ids":["https://openalex.org/I3018323443"]},{"raw_affiliation_string":"Laboratoire de Greffe de Moelle et Laboratoire d'h\u00e9matologie, Universit\u00e9 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and","institution_ids":["https://openalex.org/I3018323443"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109561315","display_name":"John M. Goldman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John M. Goldman","raw_affiliation_strings":["Department of Haematology, Imperial College of Science, Technology and Medicine, Hammersmith Hospital, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, Imperial College of Science, Technology and Medicine, Hammersmith Hospital, London, UK","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109880288","display_name":"Junia V. Melo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Junia V. Melo","raw_affiliation_strings":["Department of Haematology, Imperial College of Science, Technology and Medicine, Hammersmith Hospital, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, Imperial College of Science, Technology and Medicine, Hammersmith Hospital, London, UK","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I47508984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075844368","display_name":"Fran\u00e7ois\u2010Xavier Mahon","orcid":"https://orcid.org/0000-0003-1545-6775","observed_orcids":["https://orcid.org/0000-0003-1545-6775"]},"institutions":[{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Fran\u00e7ois Xavier Mahon","raw_affiliation_strings":["Laboratoire de Greffe de Moelle et Laboratoire d'he\u0301matologie, Universite\u0301 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and","Laboratoire de Greffe de Moelle et Laboratoire d'h\u00e9matologie, Universit\u00e9 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Greffe de Moelle et Laboratoire d'he\u0301matologie, Universite\u0301 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and","institution_ids":["https://openalex.org/I3018323443"]},{"raw_affiliation_string":"Laboratoire de Greffe de Moelle et Laboratoire d'h\u00e9matologie, Universit\u00e9 Victor Segalen and Service des Maladies du Sang, CHU de Bordeaux, Bordeaux, France, and","institution_ids":["https://openalex.org/I3018323443"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5075844368"],"corresponding_institution_ids":["https://openalex.org/I3018323443"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":3.2433,"has_fulltext":true,"cited_by_count":45,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.92315998,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"119","issue":"1","first_page":"109","last_page":"111"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9610000252723694},{"id":"https://openalex.org/keywords/bcr-abl","display_name":"BCR-ABL","score":0.8619999885559082},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.8450000286102295},{"id":"https://openalex.org/keywords/imatinib-mesylate","display_name":"imatinib mesylate","score":0.9139999747276306},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.875},{"id":"https://openalex.org/keywords/e255k-mutation","display_name":"E255K mutation","score":0.8289999961853027},{"id":"https://openalex.org/keywords/atp-binding-site","display_name":"ATP binding site","score":0.7229999899864197},{"id":"https://openalex.org/keywords/tyrosine-kinase-domain","display_name":"tyrosine kinase domain","score":0.8880000114440918},{"id":"https://openalex.org/keywords/point-mutations","display_name":"point mutations","score":0.7860000133514404},{"id":"https://openalex.org/keywords/abl-kinase-inhibitors","display_name":"ABL kinase inhibitors","score":0.6389999985694885}],"concepts":[{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.7431581616401672},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.633051872253418},{"id":"https://openalex.org/C125418893","wikidata":"https://www.wikidata.org/wiki/Q587961","display_name":"ABL","level":4,"score":0.6243525743484497},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6097604036331177},{"id":"https://openalex.org/C32619005","wikidata":"https://www.wikidata.org/wiki/Q24768234","display_name":"Protein kinase domain","level":4,"score":0.5926331877708435},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.5914614796638489},{"id":"https://openalex.org/C176944494","wikidata":"https://www.wikidata.org/wiki/Q1415380","display_name":"Point mutation","level":4,"score":0.5810254216194153},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5605226159095764},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5334919095039368},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.5253252983093262},{"id":"https://openalex.org/C2778904597","wikidata":"https://www.wikidata.org/wiki/Q1129111","display_name":"Philadelphia chromosome","level":4,"score":0.4706494212150574},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4043503403663635},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35918372869491577},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2564477324485779},{"id":"https://openalex.org/C138626823","wikidata":"https://www.wikidata.org/wiki/Q916504","display_name":"Chromosomal translocation","level":3,"score":0.18614721298217773},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1736672818660736},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.09263619780540466},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.06530916690826416},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.05990627408027649},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000255","descriptor_name":"Adenosine Triphosphate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D016044","descriptor_name":"Fusion Proteins, bcr-abl","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016044","descriptor_name":"Fusion Proteins, bcr-abl","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D017354","descriptor_name":"Point Mutation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019943","descriptor_name":"Amino Acid Substitution","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1365-2141.2002.03708.x","doi":"https://doi.org/10.1046/j.1365-2141.2002.03708.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1365-2141.2002.03708.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2141.2002.03708.x","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:12358910","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12358910","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Case Reports"}],"best_oa_location":{"id":"doi:10.1046/j.1365-2141.2002.03708.x","doi":"https://doi.org/10.1046/j.1365-2141.2002.03708.x","is_oa":true,"landing_page_url":"https://doi.org/10.1046/j.1365-2141.2002.03708.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2141.2002.03708.x","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320309749","display_name":"Association pour la Recherche sur le Cancer","ror":"https://ror.org/0489qz649"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1985238075.pdf","grobid_xml":"https://content.openalex.org/works/W1985238075.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W120676909","https://openalex.org/W1490418776","https://openalex.org/W1964306758","https://openalex.org/W1965295262","https://openalex.org/W1999614615","https://openalex.org/W2107015590","https://openalex.org/W2131174104","https://openalex.org/W2263837564","https://openalex.org/W2312804644","https://openalex.org/W2329648702"],"related_works":["https://openalex.org/W2363946741","https://openalex.org/W2069153761","https://openalex.org/W2026389791","https://openalex.org/W1965295262","https://openalex.org/W2090738258","https://openalex.org/W1999614615","https://openalex.org/W2156382022","https://openalex.org/W1965956395","https://openalex.org/W2029756715"],"abstract_inverted_index":{"The":[0],"Abl":[1,71],"kinase":[2,47,85],"inhibitor":[3],"STI571":[4,36],"(imatinib":[5],"mesylate)":[6],"induces":[7],"haematological":[8],"remissions":[9],"in":[10,31,44,58,69,82],"many":[11],"patients":[12],"with":[13,38],"chronic":[14],"myeloid":[15],"leukaemia":[16],"(CML)":[17],"but":[18],"advanced":[19],"stage":[20],"CML":[21],"usually":[22],"becomes":[23],"resistant":[24],"to":[25,35,53,62,94],"STI571.":[26,95],"We":[27,75],"describe":[28],"a":[29,42,51,59],"patient":[30],"whom":[32],"progressive":[33,91],"resistance":[34,93],"correlated":[37],"the":[39,45,70,78,83],"appearance":[40],"of":[41,80,87],"mutation":[43],"Bcr-Abl":[46,88],"domain.":[48],"This":[49],"was":[50],"G":[52],"A":[54],"transition":[55],"that":[56,77],"resulted":[57],"glutamic":[60],"acid":[61],"lysine":[63],"substitution":[64],"at":[65],"position":[66],"255":[67],"(E255K)":[68],"type":[72],"1a":[73],"protein.":[74],"suggest":[76],"acquisition":[79],"point-mutations":[81],"tyrosine":[84],"domain":[86],"may":[89],"cause":[90],"clinical":[92]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1985238075","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
